Plasma Extracellular Vesicles Identify Patients With Prodromal‐ and Alzheimer's Disease Through Their Proteomic Content

Abstract

Background: Alzheimer's disease (AD) is commonly diagnosed when neuronal damage is already established and irreversible. A differential diagnosis in the mild cognitive impairment (MCI) stage is one of the greatest challenges nowadays.